山西地区基因C型慢性乙型肝炎中医证候特点研究
|
摘要
目的
乙型肝炎病毒(Hepatitis B virus,HBV)感染是世界性的健康问题,乙肝病毒特性及宿主免疫机制紊乱等因素导致HBV感染慢性化,乙型肝炎慢性迁延而最终导致肝硬化、肝细胞癌。全球约有100万人每年死于乙型肝炎后肝硬化、肝细胞癌。慢性乙型肝炎已成为严重威胁人类健康的传染性疾病,因此慢性乙型肝炎的防治问题变得尤为重要。
HBV感染后,机体对病毒的清除能力以及感染后疾病的转归,在很大程度上取决于个体间基因组的差异和病毒基因型的差异。我国最常见的是基因型B和C。不同的HBV基因型所导致的慢性乙型肝炎(Chronic Hepatitis B,CHB)患者的发病率也不同。流行病调查显示,与B基因型相比,C基因型慢性HBV感染者的病毒载量较高,HBV活动性复制的持续时间较长,HBeAg血清学转换时间较晚,抗病毒疗效较差,是肝细胞肝癌与肝硬化发展的高危因素之一。山西地区是我国HBV感染的高发区,基因C型为其主要基因型,因此确定合理的CHB的治疗方案是当前急需解决的问题。
慢性乙型肝炎在中医医学中属于“胁痛”、“黄疸”、“肝着”等范畴。近年来中医辨证论治在CHB的治疗中发挥着重要的作用。辨证论治是中医诊断疾病和治疗疾病的基本原则,其中辨证起着关键的指导作用,是论治的基础。而相同的疾病,可由于疾病的不同阶段、患者所在地区以及患者的体质、季节等因素,出现不同的临床表现。大量的临床观察和基础研究表明,中医药具有抗病毒、调节免疫、改善临床症状以及防治肝纤维化等综合作用,但目前仍有许多关键问题有待解决。由于慢性乙型肝炎病机复杂,且由于各地地域及优势基因型的差异,辨证标准至今尚未统一,疗效评价体系尚不完善,尤其是慢性乙型肝炎的中医证候及辨证规律缺乏规范化研究,不利于指导临床。考虑到山西地区气候、地域及宿主因素等对慢性乙型肝炎中医证型的影响,为此本研究借鉴中医证候量表和多元统计方法,以大样本的山西地区慢性乙型肝炎患者为研究对象,从中提取相应的证素,应用因子分析、主成分分析等多元统计方法明确山西地区慢性乙型肝炎患者中医证型特点,同时借助双脱氧核酸法检测山西地区HBV基因型。在此基础上,分析山西地区基因C型慢性乙型肝炎患者患者的中医证候学特点,为优化山西地区慢性乙型肝炎患者治疗方案提供一定的依据。
方法
在广泛查阅相关文献的基础上,收集山西地区慢性乙型肝炎患者的中医症状,建立临床流调问卷条目池,咨询相关专家并根据相关标准,确定所需调查的中医症状条目池以及相应的症状分级量化标准,最终形成中医证侯临床调查问卷表。按统一问卷表收集慢性乙型肝炎患者的临床证候资料,应用主成分分析及因子分析等多元统计方法分析研究山西地区慢性乙型肝炎中医证候特点。同时,应用双脱氧核酸法检测山西地区慢性乙型肝炎患者HBV基因型。在此基础上,探讨山西地区慢性乙型肝炎患者的优势基因型,以及HBV基因型与所得出的中医证型及临床指标之间的关系。
结果
1对所收集到的420例山西地区慢性乙型肝炎患者的中医症状进行多元统计学方法分析,结果显示山西地区慢性乙型肝炎患者的中医证候可归纳为无证可辨型、肝郁脾虚型、肝胆湿热型、肝肾阴虚型及肝血瘀阻型五种证型。
2经双脱氧核酸法分析山西地区HBV基因型,结果提示山西地区以C型为优势基因型。其次为B/C和B型。进一步分析显示,基因C型患者中医证型以肝郁脾虚和肝胆湿热型为主,不同中医证型的舌象、苔质及脉象具有各自的特点,中医证型与肝炎分型关系密切。
3把基因C型的慢性乙型肝炎患者按轻、中、重度分为三组,结果显示不同的中医证型在肝炎分型中的分布不同。轻度主要见于无证可辨型、肝郁脾虚型和肝胆湿热型,慢性乙型肝炎重度主要见于肝肾阴虚型和肝血瘀阻型。肝郁脾虚型和肝胆湿热型在各个阶段均有分布,但随着病情的加重,其比例有逐渐递减的趋向；肝血瘀阻型主要见于慢性乙型肝炎中度、重度,轻度也有小比例的涉及；肝肾阴虚型则仅见于中、重度,未见于轻度。
4基因C型慢性乙型肝炎患者各中医证型间HBVDNA定量无明显相关性。
5基因C型的轻度慢性乙型肝炎患者肝组织炎症活动度和纤维化程度与中医证型有明显相关性,其中肝血瘀阻型患者肝组织损伤最为严重。
结论
山西地区慢性乙型肝炎患者以基因C型为主要优势,中医证候类型有无证可辨、肝郁脾虚型、肝胆湿热型、肝肾阴虚型及肝血瘀阻型五种,其中以肝郁脾虚和肝胆湿热型为主,肝血瘀阻型次之。基因C型慢性乙型肝炎患者中医证型与肝炎分度、肝组织病理关系密切,与HBVDNA数值无明显相关性。
Objective:
Hepatitis B virus (HBV) infection is a worldwide health problems. HBV factors such as the characteristics and mechanism of host immune disorder lead to chronic HBV infection, and eventually lead to cirrhosis and hepatocellular carcinoma (HCC). There are about1million people worldwide died of liver cirrhosis and HCC each year. The problem of prevention and control about HBV is particularly important because HBV infectious diseases has become a serious threat to human health.
After HBV infection, It depends on the difference between the genomes of individual and virus genotype difference to a large extent that the body's ability to clear the virus and the outcome after infection. The genotype B and C are the most common in our countiy. The Chronic Hepatitis B (CHB) caused by different HBV genotypes have the different incidence for patients. Compared with genotype B, the viral load of the patients with C genotype is higher, the duration of active HBV replication is longer, HBeAg seroconversion time is later, and antiviral effect is poorer by Epidemic survey. Genotype C is one of the high-risk factors for the development of hepatocellular carcinoma and liver cirrhosis. HBV genotype C is main genotype of Shanxi region, which has the high incidence of infection.So it is an urgent need to solve the problem for the reasonable treatment of CHB currently.
Chronic hepatitis B belongs to the "Hypochondriac","Jaundice" in the Traditional Chinese Medcine(TCM) category. In recent years, Chinese medicine syndrome differentiation and treatment in the treatment of CHB plays a vital role. Treatment based on syndrome differentiation of TCM is the basic principle of diagnosis and treatment of diseases. The differentiation plays a key role in guiding, and is the foundation of treatment. The same disease appears different clinical manifestations, due to the different stages of disease, patients region, and the patient's constitution, seasonal factors, and so on.A large number of clinical observation and basic research shows that Chinese medicine has antiviral action, immune regulation, the prevention and treatment of liver fibrosis combination, and improving the clinical symptoms.But there are still many key problems should be solved at present. Due to the complexity of pathogenesis of CHB, and because the advantages of genotype differences around the region, syndrome differentiation standard has not been unity, and curative effect evaluation system is not perfect, especially the TCM syndromes of CHB is not conducive to guide clinicalbecause the lack of standardization research.Considering the shanxi region climate, geography, and host factors impact on the TCM syndrome types of CHB, we will extract the corresponding syndrome elements and carry out the syndrome of Shanxi region by cluster analysis, factor analysis, principal component analysis of multivariate statistical methods, and detect HBV genotype by Sanger nuceic acid method. Finally,we will study the corresponding relationship between TCM syndrome and HBV genotype with clinical indicators.
Methods:
Based on extensively reviewing the relevant literature, collected the clinical symptoms of TCM of the ascites with CHB, then established an initially clinical epidemiological survey questionnaire. At last, determined the required clinical symptoms of the survey questionnaire item pool in TCM, and made the corresponding classification of quantitative criteria symptoms by relevant expert advice and feasibility analysis, repeated discussions and seminars and clinical research guidelines. Used uniform questionnaire to collect clinical syndromes data of the ascites with CHB. We use the method of factor analysis to investigate its characteristics of TCM syndrome, and to discuss the relationship between the objective indexes with the characteristics of TCM.
Results:
1The results show that the TCM syndrome in patients with CHB in shanxi region can be summarized five types by multivariate statistical analysis with collected clinical data of420cases,including Unlicensed discernible type, liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder deficiency of liver-yin and kidney-yin and obstruction of collaterals by blood stasis.
2HBV genotypes in shanxi region is analyzed by Dideoxy method of nucleic acid suggests genotype C is the most prevalent followed by B/C and B in Shanxi Province.Further analysis showed that patients with genotype C syndrome type of traditional Chinese medicine is given priority to with dampness heat resistance, blood stasis resistance type winding times, TCM syndrome type and hepatitis, is close to the parting and HBVDNA quantitative no significant correlation.
3The genotype C in patients with CHB are divided into three groups with light, medium and heavy, the results showed different distribution of TCM syndrome in hepatitis is different. The mild is mainly seen in Unlicensed discernible type, liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder,the severe is mainly seen in deficiency of liver-yin and kidney-yin and obstruction of collaterals by blood stasis, iver stagnation and spleen deficiency,detness-Heat of Liver and Gallbladder can be distributed in each stage, however, as the illness is aggravating, its ratio have gradually decreasing trend. The obstruction of collaterals by blood stasis can be seen mainly in moderate and severe CHB, mild and there's a small proportion of the involved.Deficiency of liver-yin and kidney-yin is restricted to medium, heavy, not in light.
4The TCM syndrome of CHB has no significant correlation with the quantity of HBVDNA.
5Genotype C of mild CHB patients with liver tissue inflammation activity and fibrosis degree has obvious correlation with TCM syndrome types, while the syndrome of obstruction of collaterals by blood stasis is most severe in patients with liver injury.
Conclusion:
Genotype C is the most prevalent followed by B/C and B in Shanxi Province. The syndrome in patients with CHB in shanxi region can be summarized five types by multivariate statistical analysis,including Unlicensed discernible type, liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder,deficiency of liver-yin and kidney-yin and obstruction of collaterals by blood stasis. The syndromes of liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder are the most types of all, The syndromes are closely related to disease and liver tissue pathology,but no significant correlation with te quantity of HBVDNA.
乙型肝炎病毒(Hepatitis B virus,HBV)感染是世界性的健康问题,乙肝病毒特性及宿主免疫机制紊乱等因素导致HBV感染慢性化,乙型肝炎慢性迁延而最终导致肝硬化、肝细胞癌。全球约有100万人每年死于乙型肝炎后肝硬化、肝细胞癌。慢性乙型肝炎已成为严重威胁人类健康的传染性疾病,因此慢性乙型肝炎的防治问题变得尤为重要。
HBV感染后,机体对病毒的清除能力以及感染后疾病的转归,在很大程度上取决于个体间基因组的差异和病毒基因型的差异。我国最常见的是基因型B和C。不同的HBV基因型所导致的慢性乙型肝炎(Chronic Hepatitis B,CHB)患者的发病率也不同。流行病调查显示,与B基因型相比,C基因型慢性HBV感染者的病毒载量较高,HBV活动性复制的持续时间较长,HBeAg血清学转换时间较晚,抗病毒疗效较差,是肝细胞肝癌与肝硬化发展的高危因素之一。山西地区是我国HBV感染的高发区,基因C型为其主要基因型,因此确定合理的CHB的治疗方案是当前急需解决的问题。
慢性乙型肝炎在中医医学中属于“胁痛”、“黄疸”、“肝着”等范畴。近年来中医辨证论治在CHB的治疗中发挥着重要的作用。辨证论治是中医诊断疾病和治疗疾病的基本原则,其中辨证起着关键的指导作用,是论治的基础。而相同的疾病,可由于疾病的不同阶段、患者所在地区以及患者的体质、季节等因素,出现不同的临床表现。大量的临床观察和基础研究表明,中医药具有抗病毒、调节免疫、改善临床症状以及防治肝纤维化等综合作用,但目前仍有许多关键问题有待解决。由于慢性乙型肝炎病机复杂,且由于各地地域及优势基因型的差异,辨证标准至今尚未统一,疗效评价体系尚不完善,尤其是慢性乙型肝炎的中医证候及辨证规律缺乏规范化研究,不利于指导临床。考虑到山西地区气候、地域及宿主因素等对慢性乙型肝炎中医证型的影响,为此本研究借鉴中医证候量表和多元统计方法,以大样本的山西地区慢性乙型肝炎患者为研究对象,从中提取相应的证素,应用因子分析、主成分分析等多元统计方法明确山西地区慢性乙型肝炎患者中医证型特点,同时借助双脱氧核酸法检测山西地区HBV基因型。在此基础上,分析山西地区基因C型慢性乙型肝炎患者患者的中医证候学特点,为优化山西地区慢性乙型肝炎患者治疗方案提供一定的依据。
方法
在广泛查阅相关文献的基础上,收集山西地区慢性乙型肝炎患者的中医症状,建立临床流调问卷条目池,咨询相关专家并根据相关标准,确定所需调查的中医症状条目池以及相应的症状分级量化标准,最终形成中医证侯临床调查问卷表。按统一问卷表收集慢性乙型肝炎患者的临床证候资料,应用主成分分析及因子分析等多元统计方法分析研究山西地区慢性乙型肝炎中医证候特点。同时,应用双脱氧核酸法检测山西地区慢性乙型肝炎患者HBV基因型。在此基础上,探讨山西地区慢性乙型肝炎患者的优势基因型,以及HBV基因型与所得出的中医证型及临床指标之间的关系。
结果
1对所收集到的420例山西地区慢性乙型肝炎患者的中医症状进行多元统计学方法分析,结果显示山西地区慢性乙型肝炎患者的中医证候可归纳为无证可辨型、肝郁脾虚型、肝胆湿热型、肝肾阴虚型及肝血瘀阻型五种证型。
2经双脱氧核酸法分析山西地区HBV基因型,结果提示山西地区以C型为优势基因型。其次为B/C和B型。进一步分析显示,基因C型患者中医证型以肝郁脾虚和肝胆湿热型为主,不同中医证型的舌象、苔质及脉象具有各自的特点,中医证型与肝炎分型关系密切。
3把基因C型的慢性乙型肝炎患者按轻、中、重度分为三组,结果显示不同的中医证型在肝炎分型中的分布不同。轻度主要见于无证可辨型、肝郁脾虚型和肝胆湿热型,慢性乙型肝炎重度主要见于肝肾阴虚型和肝血瘀阻型。肝郁脾虚型和肝胆湿热型在各个阶段均有分布,但随着病情的加重,其比例有逐渐递减的趋向；肝血瘀阻型主要见于慢性乙型肝炎中度、重度,轻度也有小比例的涉及；肝肾阴虚型则仅见于中、重度,未见于轻度。
4基因C型慢性乙型肝炎患者各中医证型间HBVDNA定量无明显相关性。
5基因C型的轻度慢性乙型肝炎患者肝组织炎症活动度和纤维化程度与中医证型有明显相关性,其中肝血瘀阻型患者肝组织损伤最为严重。
结论
山西地区慢性乙型肝炎患者以基因C型为主要优势,中医证候类型有无证可辨、肝郁脾虚型、肝胆湿热型、肝肾阴虚型及肝血瘀阻型五种,其中以肝郁脾虚和肝胆湿热型为主,肝血瘀阻型次之。基因C型慢性乙型肝炎患者中医证型与肝炎分度、肝组织病理关系密切,与HBVDNA数值无明显相关性。
Objective:
Hepatitis B virus (HBV) infection is a worldwide health problems. HBV factors such as the characteristics and mechanism of host immune disorder lead to chronic HBV infection, and eventually lead to cirrhosis and hepatocellular carcinoma (HCC). There are about1million people worldwide died of liver cirrhosis and HCC each year. The problem of prevention and control about HBV is particularly important because HBV infectious diseases has become a serious threat to human health.
After HBV infection, It depends on the difference between the genomes of individual and virus genotype difference to a large extent that the body's ability to clear the virus and the outcome after infection. The genotype B and C are the most common in our countiy. The Chronic Hepatitis B (CHB) caused by different HBV genotypes have the different incidence for patients. Compared with genotype B, the viral load of the patients with C genotype is higher, the duration of active HBV replication is longer, HBeAg seroconversion time is later, and antiviral effect is poorer by Epidemic survey. Genotype C is one of the high-risk factors for the development of hepatocellular carcinoma and liver cirrhosis. HBV genotype C is main genotype of Shanxi region, which has the high incidence of infection.So it is an urgent need to solve the problem for the reasonable treatment of CHB currently.
Chronic hepatitis B belongs to the "Hypochondriac","Jaundice" in the Traditional Chinese Medcine(TCM) category. In recent years, Chinese medicine syndrome differentiation and treatment in the treatment of CHB plays a vital role. Treatment based on syndrome differentiation of TCM is the basic principle of diagnosis and treatment of diseases. The differentiation plays a key role in guiding, and is the foundation of treatment. The same disease appears different clinical manifestations, due to the different stages of disease, patients region, and the patient's constitution, seasonal factors, and so on.A large number of clinical observation and basic research shows that Chinese medicine has antiviral action, immune regulation, the prevention and treatment of liver fibrosis combination, and improving the clinical symptoms.But there are still many key problems should be solved at present. Due to the complexity of pathogenesis of CHB, and because the advantages of genotype differences around the region, syndrome differentiation standard has not been unity, and curative effect evaluation system is not perfect, especially the TCM syndromes of CHB is not conducive to guide clinicalbecause the lack of standardization research.Considering the shanxi region climate, geography, and host factors impact on the TCM syndrome types of CHB, we will extract the corresponding syndrome elements and carry out the syndrome of Shanxi region by cluster analysis, factor analysis, principal component analysis of multivariate statistical methods, and detect HBV genotype by Sanger nuceic acid method. Finally,we will study the corresponding relationship between TCM syndrome and HBV genotype with clinical indicators.
Methods:
Based on extensively reviewing the relevant literature, collected the clinical symptoms of TCM of the ascites with CHB, then established an initially clinical epidemiological survey questionnaire. At last, determined the required clinical symptoms of the survey questionnaire item pool in TCM, and made the corresponding classification of quantitative criteria symptoms by relevant expert advice and feasibility analysis, repeated discussions and seminars and clinical research guidelines. Used uniform questionnaire to collect clinical syndromes data of the ascites with CHB. We use the method of factor analysis to investigate its characteristics of TCM syndrome, and to discuss the relationship between the objective indexes with the characteristics of TCM.
Results:
1The results show that the TCM syndrome in patients with CHB in shanxi region can be summarized five types by multivariate statistical analysis with collected clinical data of420cases,including Unlicensed discernible type, liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder deficiency of liver-yin and kidney-yin and obstruction of collaterals by blood stasis.
2HBV genotypes in shanxi region is analyzed by Dideoxy method of nucleic acid suggests genotype C is the most prevalent followed by B/C and B in Shanxi Province.Further analysis showed that patients with genotype C syndrome type of traditional Chinese medicine is given priority to with dampness heat resistance, blood stasis resistance type winding times, TCM syndrome type and hepatitis, is close to the parting and HBVDNA quantitative no significant correlation.
3The genotype C in patients with CHB are divided into three groups with light, medium and heavy, the results showed different distribution of TCM syndrome in hepatitis is different. The mild is mainly seen in Unlicensed discernible type, liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder,the severe is mainly seen in deficiency of liver-yin and kidney-yin and obstruction of collaterals by blood stasis, iver stagnation and spleen deficiency,detness-Heat of Liver and Gallbladder can be distributed in each stage, however, as the illness is aggravating, its ratio have gradually decreasing trend. The obstruction of collaterals by blood stasis can be seen mainly in moderate and severe CHB, mild and there's a small proportion of the involved.Deficiency of liver-yin and kidney-yin is restricted to medium, heavy, not in light.
4The TCM syndrome of CHB has no significant correlation with the quantity of HBVDNA.
5Genotype C of mild CHB patients with liver tissue inflammation activity and fibrosis degree has obvious correlation with TCM syndrome types, while the syndrome of obstruction of collaterals by blood stasis is most severe in patients with liver injury.
Conclusion:
Genotype C is the most prevalent followed by B/C and B in Shanxi Province. The syndrome in patients with CHB in shanxi region can be summarized five types by multivariate statistical analysis,including Unlicensed discernible type, liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder,deficiency of liver-yin and kidney-yin and obstruction of collaterals by blood stasis. The syndromes of liver stagnation and spleen deficiency, wetness-Heat of Liver and Gallbladder are the most types of all, The syndromes are closely related to disease and liver tissue pathology,but no significant correlation with te quantity of HBVDNA.
引文
[1]党国宏,高昱.慢性乙型肝炎中医病机的探讨[J].延安大学学报,2007,5(2)：62-63
[2]杨诗杰,苏汝好,吴泰相,等.中西药结合与单用西药治疗慢性乙型肝炎随机对照试验的统评价研究方案[J].时珍国医国药,2007,18(5)：1104-1106
[3]李筠.慢性重型肝炎中医辨证与临床分期及预后分析[J].中西医结合肝病杂志,2007,17(6)：343-344
[4]吴继勇.彭胜权教授治疗肝病经验[J].新中医,2000,32(1)：8-9
[5]赵汉鸣,吴德光诊治“乙肝”经验[J].江西中医药,2000,31(4)：3-4
[6]刘绍能,吕文良.慢性乙型肝炎肝纤维化辨证分型的研究[J].中医药信息,2002,19(5)：15-16
[7]邓华亮,王玉娟,张少军.慢性乙型肝炎中医证候规范化研究的思考[J].山东中医药大学学报,2013,37(3)：182-183
[8]叶永安,江锋,赵志敏,等.慢性乙型肝炎中医证型分布规律研究[J].中医杂志,2007,48(3)：256-258
[9]陈玮.福州市区慢性乙型肝炎抗病毒治疗患者中医证型调查分析[D].福州：福建中医学院,2009
[10]黄升腾,许光宏.台湾地区慢性乙型肝炎中医辨证论治规律探讨[J].中西医结合肝病杂志,2002,12(6)：329-333
[11]黄贤樟.乙型肝炎的中医证治规律探讨[J].新中医,2001,33(1)：8-9
[12]池晓玲.岭南地区慢性乙型肝炎诊治因人制宜的规律研究[J].环球中医药,2012,5(5)：359-361
[13]吴春城.闽南地区慢性乙型肝炎中医证型分布及人口学和生物学基础[D].福建：福建中医药大学,2010
[14]陆永钊.广东省慢性乙型病毒性肝炎(活动期)中医证型分布文献分析的研究[D].广州：广州中医药大学,2010
[15]赵庆,唐瑛,易娟,等.西南地区慢性乙型肝炎肝肾阴虚证的特点分析[J].内蒙古中医药,2013,32(2)：117
[16]赵庆.宋丽娟.陈苏,等.不同地域慢性乙肝肝肾阴虚证与肝功能及四诊信息的相关差异性研究[J].辽宁中医药大学学报,2011,13(2)：106-108
[17]徐徊溪.医学源流论[M].北京：人民卫生出版社,1956
[18]庄泓,江家骥.中医体质和宿主基因与HBV慢性感染的关系[J].中西医结合杂志,2003,13(5)：270-274
[19]张明亚.论乙肝病毒携带者与体质强弱的辨治[J].光明中医.1998,13(76)：11-12
[20]池晓玲,蒋俊民,蔡高术,等.从五行人体质探讨慢性乙型肝炎的诊治规律[J].世界中医药,2011,6(6)：518-520
[21]李瀚曼,毛树松,鲍罡,等.张大钊教授治疗慢性肝病中医辨证规律研究[J].中国药物与临床,2004,4(11)：821-823
[22]荀运浩,过建春,施军平,等.中医体质与慢性HBV感染者肝纤维化的相关性探讨[J].中 国中医药科技,2009,16(4)：249-250
[23]Kato H,Gish RG,Bzowe jN,et al.Eight genotypes (A-H) of hepatitis B virus infecting patients from SanFrancisco and their demographic,clinical,and virological characteristics [J]. J Med Virol.2004,73(4):516-521
[24]李筠,杨慧银,王立福,等.慢性乙型肝炎病毒脱氧核糖核酸基因型与中医辨证规律初探[J].中国中西医结合杂志,2010,30(10)：1045-1048
[25]许剑,何鲜平,吴孟晋.慢性乙型肝炎患者HBV基因型与中医辨证分型的相关性[J].四川中医,2011,29(1)：17-18
[26]杨慧银,周双男,王立福,等.慢性乙型肝炎病毒基因分型与中医辨证规律初探[J].传染病信息,2010,23(5)：291-295
[27]江锋,王宗殿.中医证候本质研究的回顾与思考[J].中医药学刊,2005,23(1)：131-133
[28]田松.多元统计分析方法在医学科研中的应用[J].广西医学,2006,28(2)：298-302
[29]朱文锋,晏峻峰.证素辨证新体系的内容及科学意义[J].医学与哲学,2005,26(1)：69-70
[30]田松.多元分析方法在辨证论治研究中的应用现状与思考[J].山西中医学院学报,2007,8(3)：54-55
[31]田松.多元统计分析方法在辨证论治研究中的作用探析[J].中国中医药信息杂志,2007,14(7)：5-6
[32]刘震.慢性乙型肝炎、早期肝硬化毒损肝络病机及其证候特点的研究[D].北京：中国中医科学院,2006
[33]俞伟,聂广,盛国光,等.慢性乙型肝炎患者辨证分型与实验室检测指标的相关性研究及多元线性诊断方程的建立[J].中西医结合肝病杂志,1997,7(4)：204-213
[34]张琴,刘平,陈惠芬,等.肝炎肝硬化中医证候特点的多元分析[J].中西医结合肝病杂志,2003,13(2)：69-72
[35]茹淑瑛,江锋,叶永安.中医证素研究中多元统计分析方法的应用解析[J].中国中医基础医学杂志,2012,18(6)：612-613
[1]张福奎,贾继东,王宝恩.慢性乙型肝炎的治疗[J].中华肝脏病杂志,2000,8(4)：253-255
[2]Kao J H,Chen D S.Global control of hepatitis B virus infection[J]. Lancet Infect Dis, 2002,2(7):395-403
[3]World Health Organization.Hepatitis B.World Health Organization 204 dex (Revised October 2000).WHO Website. http://www.who,Int/mediaeentre/factsheets/fs204/en/in html
[4]Nowak,M.A.,S.Bonhoeffer,A. M. Hill,et al.Viral dynamics in hepatitis B virus infection [J].Proc Natl Acad Sci U S A.1996,93(9):4398-4402
[5]Akuta N,Kumada H.Influence of hepatitis B virus genotypes on the response to Antiviral therapies[J].J Antimicrob Chemother,2005,55(2):139-142
[6]王蕾,刘华,宁小晓,等HBsAg和HBsAb双阳性慢性乙肝患者血清中HBV基因型与S区突变的关系[J].上海交通大学学报,2010,30(10)：1226-1230
[7]Kramvis A,Weitzmann L,Owiredu WK,et al. Analysis of the complete genome of subgroup A Hepaitis B virus isolates from South Africa[J].J GenVirol,2002,83(Pt 4):835-839
[8]Kurbanov F,Tanaka Y,Fujiwara K,et al.A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and Ein Cameroon[J].J Gen Virol,2005, 86(Pt 7):2047-2056
[9]Sugauchi F,Orito E,Ichida T,et al.Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene[J].J Virol,2002, 76(12):5985-5992
[10]Shi YH.Correlation between hepatitis b virus genotypes and clinical outcomes[J].J Infect Dis,2012,65(6):476-482
[11]Chu CJ,Keeffe EB,Han SH,et al.Hepatitis B virus genotypes in the United States:result of a nationwide study [J].Gastroenterology,2003,125(2):444-451
[12]Iran TT,Trinh TN,Abe K.New complex recombinant genotype of hepatitis B virus identified in Vietnam[J].J Virol,2008,82(11):5657-5663
[13]殷继明,金荣华,严艳,等.慢性乙型肝炎患者HBV基因型和亚型分布调查[J].实用肝脏病杂志,2010,13(1)：19-21
[14]任来峰,申元英,赵树强,等.山西省HBV基因型及亚型分布调查[J].中国病原生物学杂志,2014,9(3)：264-267
[15]郭晓霞,叶永安.山西省HBV基因型分布特点和临床意义[J].中西医结合肝病杂志,2012,22(3)：170-175
[16]Wang Z,Liu Z,Zeng G,et al.A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China[J].J Gen Virol,2005,86(Pt 4):985-990
[17]Kato H,Gish RG,Bzowej N,et al.Eight genot ypes(A-H) of hepatitis B virus infecting patients from San Francisco and their demographic,clinical,and virological characteristics [J].J Med Virol,2004,73(4):516-521
[18]Sakugawa H,Nakasone H,Nakayoshi,et al.Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa,Japan[J].J Med Virol,2002,67(4):484-489
[19]Garfein RS,Bower WA,Loney CM,et al.Factors assoeiated with fulminant liver failure during an outbreak among inject on drug users with acute hepatitis B[J].Hepatology, 2004,40(4):865-873
[20]Lu J,Gong W,Cheng H,et al.Detection of HBV genotypes of tumor tissues and serum by a Fluorescence Polarization assay in north-western China's hepatocellular carcinoma patients[J].Virol J.2011,22(8):362-362
[21]陈钦艳,李生,杨进业,等.乙型肝炎病毒新基因型Ⅰ与肝脏疾病关系的研究[J].广西医学,2014,36(1)：1-4
[22]周清荣,张圆海,刁仁联.乙型肝炎病毒基因型的分布及与临床相关性[J].实用肝脏病杂志,2006,9(6)：349-351
[23]严艳,李卓,殷继明,等.北京地区乙型肝炎病毒基因型及基因亚型的分布和临床意义[J].中国误诊学杂志,2008,8(15)：3537-3539
[24]Chan H L,Wong M L,Hui A Y,et al.Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients [J].J Clin Microbiol,2003,41 (3):1277-1279
[25]Chan H L,Hui A Y,Wong M L,et al.Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma[J].Gut,2004,53(10):1494-1498
[26]许正据,杨红,陈先礼,等.重型肝炎患者乙型肝炎病毒基因型及其进化树分析[J].中华肝脏病杂志,2006,14(10)：785-787
[27]殷建华,周赟,何永超,等.乙型肝炎病毒基因亚型B2和C2对肝细胞癌形成、疗效及预后的影响[J].第二军医大学学报2008,29(2)：162-166
[28]Kao JH,Chen PJ,Lai MY,et al.Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.J Med Virol,2004,72(3):363-369
[29]KaoJH,ChenPJ,Lai MY,et al.Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection[J].J Clin Mierobiol,2002,40(4):1207-1209
[30]Wang Z,Tanaka Y,HuangY,et al.Clinical and virological characteristics of hepatitis B virus subgenotypes Ba,Cl,and C2 in China[J].J Clin Microbiol 2007,45(5):1491-1496
[31]Thakur V,Guptan RC,Kazim SN,et al.Profile,spectrum and significance of HBVgenotypes in chronic liver disease patients in thelndian subcontinent [J].J Gastroenterol Hepatol 2002,17(2):165-170
[32]Chan HL,Tsang SW,Wong ML,et al.Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong[J].Am J Gastroenterol.2002,97(10):2629-2633
[33]Chu CJ,Hussain M,Lok AS.Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C[J].Gastroenterology, 2002,122(7):1756-1762
[34]陈金军,王战会,马世武,等.HBV基因型(B/C)是影响HBeAg阳性慢性乙型肝炎患者血清HBsAg水平的重要因素[J].临床肝胆病杂志,2009,25(4)：247-250
[35]周平,谢仁江.聚乙二醇α-干扰素治疗慢性乙型肝炎的研究进展[J].世界华人消化杂志,2005,13(14)：1747-1749
[36]周霞,王宇明.乙型肝炎病毒基因分型研究进展[J].重庆医学,2008,37(1)：91-93
[37]Wai CT,Chu CJ,Hussain M,et al.HBV genotype B is associated with better response to Interferon therapy in HBeAg(+) chronic hepatitis than genotype C[J].Hepatology,2002, 36(6):1425-1430
[38]Sanchez-Tapias JM,Cost a J,Mas A,et al.Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients [J].Gastroenterology,2002, 123(6):1848-1856
[39]汤佳良,许文芳,吴勇.病毒基因型对联合抗病毒治疗慢性乙型肝炎患者HBVDNA、 HBeAg变化的影响[J].中国卫生检验杂志,2011,21(12)：2905-2906
[40]Mizokami M,Nakano T,Orito E,et al.Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns [J].FEBS Lett,1999,450(1-2):66.71.
[41]Usuda,S. H.Okamoto,T.Tanaka,et al. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product [J].J Virol Methods,2000,87(1-2):81-89.
[42]Naito,H.,S.Hayashi,and K.Abe. Rapid and specific genotyping System for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers [J].J Clin Microbiol,2001,39(1):362-364.
[43]王虹,王省良,万成松,李涛.采用微板核酸杂交-ELISA技术进行HBVDNA基因分型的研究.中华微生物和免疫学杂志,2001,21(2)：234-236.
[1]Kao J H,Chen D S.Global control of hepatitis B virus infection[J].Lancet Infect Dis,2002, 2(7):395-403
[2]Kumar K, Kumar M, Rahaman SH, et al.Distribution of Hepatitis B virus genotypes among healthy blood donors in eastern part of North India. Asian J Transfus Sci.2011,5(2): 144-149
[3]孙奎霞,李杰,闫玲,等.中国慢性乙型肝炎病毒感染者病毒基因型及基因亚型分布.中国病毒病杂志,2011,1(3)：177-182
[4]Zeng G,Wang Z,Wen S,et al.Geographic distribution,virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat.2005,12(6):609-617
[5]中华中医药学会内科肝胆病学组,世界中医药联合学会肝病专业委员会,中国中西医结合学会肝病分组.慢性乙型肝炎中医诊疗专家共识.临床肝胆病杂志,2012,28(3)：164-168.
[6]黄志杰.试论南北地域病证特点与因地制宜治则.中国中医基础医学杂志,2001,7(3)：8-10
[7]薛博瑜.慢性乙型肝炎中医临证治疗方略.药品评价,2009,6(2)：74-75
[8]叶永安,江锋,赵志敏,等.慢性乙型肝炎中医证型分布规律研究[J].中医杂志,2007,48(3)：256-258
[9]牛春红,田新强,米亚英.山西地区家族聚集性慢性乙型肝炎病毒感染者病毒载量及组织病变与基因型的关系[J].中国现代医药杂志,2009,11(7)：23-25
[10]汪莉萍,韩方正,吴光辉.HBV基因型与HBeAg的表达关系及其临床意义.临床肝胆病杂志,2011,27(5)：505-507
[11]Toan NL, Song le H, KremsnerPG, et al.Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.Hepatology,2006,43(6): 1375-1384
[12]Liu CJ, Kao JH, Chen DS.Mixed hepatitis B virus genotype infection:the more, the worse?Hepatology,2006,44(3):770-770
[13]李谋多,乔翠霞,张军勇,等.乙肝病毒携带者中医证型与HBV基因型及HBVDNA载量的关系[J].江苏中医药,2012,44(5)：18-19
[14]龙庆华,廖九女,涂德幸,等.肝活检对转氨酶轻度升高的慢性乙型肝炎的临床意义.江西医药,2009,44(5)：468-469
[2]杨诗杰,苏汝好,吴泰相,等.中西药结合与单用西药治疗慢性乙型肝炎随机对照试验的统评价研究方案[J].时珍国医国药,2007,18(5)：1104-1106
[3]李筠.慢性重型肝炎中医辨证与临床分期及预后分析[J].中西医结合肝病杂志,2007,17(6)：343-344
[4]吴继勇.彭胜权教授治疗肝病经验[J].新中医,2000,32(1)：8-9
[5]赵汉鸣,吴德光诊治“乙肝”经验[J].江西中医药,2000,31(4)：3-4
[6]刘绍能,吕文良.慢性乙型肝炎肝纤维化辨证分型的研究[J].中医药信息,2002,19(5)：15-16
[7]邓华亮,王玉娟,张少军.慢性乙型肝炎中医证候规范化研究的思考[J].山东中医药大学学报,2013,37(3)：182-183
[8]叶永安,江锋,赵志敏,等.慢性乙型肝炎中医证型分布规律研究[J].中医杂志,2007,48(3)：256-258
[9]陈玮.福州市区慢性乙型肝炎抗病毒治疗患者中医证型调查分析[D].福州：福建中医学院,2009
[10]黄升腾,许光宏.台湾地区慢性乙型肝炎中医辨证论治规律探讨[J].中西医结合肝病杂志,2002,12(6)：329-333
[11]黄贤樟.乙型肝炎的中医证治规律探讨[J].新中医,2001,33(1)：8-9
[12]池晓玲.岭南地区慢性乙型肝炎诊治因人制宜的规律研究[J].环球中医药,2012,5(5)：359-361
[13]吴春城.闽南地区慢性乙型肝炎中医证型分布及人口学和生物学基础[D].福建：福建中医药大学,2010
[14]陆永钊.广东省慢性乙型病毒性肝炎(活动期)中医证型分布文献分析的研究[D].广州：广州中医药大学,2010
[15]赵庆,唐瑛,易娟,等.西南地区慢性乙型肝炎肝肾阴虚证的特点分析[J].内蒙古中医药,2013,32(2)：117
[16]赵庆.宋丽娟.陈苏,等.不同地域慢性乙肝肝肾阴虚证与肝功能及四诊信息的相关差异性研究[J].辽宁中医药大学学报,2011,13(2)：106-108
[17]徐徊溪.医学源流论[M].北京：人民卫生出版社,1956
[18]庄泓,江家骥.中医体质和宿主基因与HBV慢性感染的关系[J].中西医结合杂志,2003,13(5)：270-274
[19]张明亚.论乙肝病毒携带者与体质强弱的辨治[J].光明中医.1998,13(76)：11-12
[20]池晓玲,蒋俊民,蔡高术,等.从五行人体质探讨慢性乙型肝炎的诊治规律[J].世界中医药,2011,6(6)：518-520
[21]李瀚曼,毛树松,鲍罡,等.张大钊教授治疗慢性肝病中医辨证规律研究[J].中国药物与临床,2004,4(11)：821-823
[22]荀运浩,过建春,施军平,等.中医体质与慢性HBV感染者肝纤维化的相关性探讨[J].中 国中医药科技,2009,16(4)：249-250
[23]Kato H,Gish RG,Bzowe jN,et al.Eight genotypes (A-H) of hepatitis B virus infecting patients from SanFrancisco and their demographic,clinical,and virological characteristics [J]. J Med Virol.2004,73(4):516-521
[24]李筠,杨慧银,王立福,等.慢性乙型肝炎病毒脱氧核糖核酸基因型与中医辨证规律初探[J].中国中西医结合杂志,2010,30(10)：1045-1048
[25]许剑,何鲜平,吴孟晋.慢性乙型肝炎患者HBV基因型与中医辨证分型的相关性[J].四川中医,2011,29(1)：17-18
[26]杨慧银,周双男,王立福,等.慢性乙型肝炎病毒基因分型与中医辨证规律初探[J].传染病信息,2010,23(5)：291-295
[27]江锋,王宗殿.中医证候本质研究的回顾与思考[J].中医药学刊,2005,23(1)：131-133
[28]田松.多元统计分析方法在医学科研中的应用[J].广西医学,2006,28(2)：298-302
[29]朱文锋,晏峻峰.证素辨证新体系的内容及科学意义[J].医学与哲学,2005,26(1)：69-70
[30]田松.多元分析方法在辨证论治研究中的应用现状与思考[J].山西中医学院学报,2007,8(3)：54-55
[31]田松.多元统计分析方法在辨证论治研究中的作用探析[J].中国中医药信息杂志,2007,14(7)：5-6
[32]刘震.慢性乙型肝炎、早期肝硬化毒损肝络病机及其证候特点的研究[D].北京：中国中医科学院,2006
[33]俞伟,聂广,盛国光,等.慢性乙型肝炎患者辨证分型与实验室检测指标的相关性研究及多元线性诊断方程的建立[J].中西医结合肝病杂志,1997,7(4)：204-213
[34]张琴,刘平,陈惠芬,等.肝炎肝硬化中医证候特点的多元分析[J].中西医结合肝病杂志,2003,13(2)：69-72
[35]茹淑瑛,江锋,叶永安.中医证素研究中多元统计分析方法的应用解析[J].中国中医基础医学杂志,2012,18(6)：612-613
[1]张福奎,贾继东,王宝恩.慢性乙型肝炎的治疗[J].中华肝脏病杂志,2000,8(4)：253-255
[2]Kao J H,Chen D S.Global control of hepatitis B virus infection[J]. Lancet Infect Dis, 2002,2(7):395-403
[3]World Health Organization.Hepatitis B.World Health Organization 204 dex (Revised October 2000).WHO Website. http://www.who,Int/mediaeentre/factsheets/fs204/en/in html
[4]Nowak,M.A.,S.Bonhoeffer,A. M. Hill,et al.Viral dynamics in hepatitis B virus infection [J].Proc Natl Acad Sci U S A.1996,93(9):4398-4402
[5]Akuta N,Kumada H.Influence of hepatitis B virus genotypes on the response to Antiviral therapies[J].J Antimicrob Chemother,2005,55(2):139-142
[6]王蕾,刘华,宁小晓,等HBsAg和HBsAb双阳性慢性乙肝患者血清中HBV基因型与S区突变的关系[J].上海交通大学学报,2010,30(10)：1226-1230
[7]Kramvis A,Weitzmann L,Owiredu WK,et al. Analysis of the complete genome of subgroup A Hepaitis B virus isolates from South Africa[J].J GenVirol,2002,83(Pt 4):835-839
[8]Kurbanov F,Tanaka Y,Fujiwara K,et al.A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and Ein Cameroon[J].J Gen Virol,2005, 86(Pt 7):2047-2056
[9]Sugauchi F,Orito E,Ichida T,et al.Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene[J].J Virol,2002, 76(12):5985-5992
[10]Shi YH.Correlation between hepatitis b virus genotypes and clinical outcomes[J].J Infect Dis,2012,65(6):476-482
[11]Chu CJ,Keeffe EB,Han SH,et al.Hepatitis B virus genotypes in the United States:result of a nationwide study [J].Gastroenterology,2003,125(2):444-451
[12]Iran TT,Trinh TN,Abe K.New complex recombinant genotype of hepatitis B virus identified in Vietnam[J].J Virol,2008,82(11):5657-5663
[13]殷继明,金荣华,严艳,等.慢性乙型肝炎患者HBV基因型和亚型分布调查[J].实用肝脏病杂志,2010,13(1)：19-21
[14]任来峰,申元英,赵树强,等.山西省HBV基因型及亚型分布调查[J].中国病原生物学杂志,2014,9(3)：264-267
[15]郭晓霞,叶永安.山西省HBV基因型分布特点和临床意义[J].中西医结合肝病杂志,2012,22(3)：170-175
[16]Wang Z,Liu Z,Zeng G,et al.A new intertype recombinant between genotypes C and D of hepatitis B virus identified in China[J].J Gen Virol,2005,86(Pt 4):985-990
[17]Kato H,Gish RG,Bzowej N,et al.Eight genot ypes(A-H) of hepatitis B virus infecting patients from San Francisco and their demographic,clinical,and virological characteristics [J].J Med Virol,2004,73(4):516-521
[18]Sakugawa H,Nakasone H,Nakayoshi,et al.Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa,Japan[J].J Med Virol,2002,67(4):484-489
[19]Garfein RS,Bower WA,Loney CM,et al.Factors assoeiated with fulminant liver failure during an outbreak among inject on drug users with acute hepatitis B[J].Hepatology, 2004,40(4):865-873
[20]Lu J,Gong W,Cheng H,et al.Detection of HBV genotypes of tumor tissues and serum by a Fluorescence Polarization assay in north-western China's hepatocellular carcinoma patients[J].Virol J.2011,22(8):362-362
[21]陈钦艳,李生,杨进业,等.乙型肝炎病毒新基因型Ⅰ与肝脏疾病关系的研究[J].广西医学,2014,36(1)：1-4
[22]周清荣,张圆海,刁仁联.乙型肝炎病毒基因型的分布及与临床相关性[J].实用肝脏病杂志,2006,9(6)：349-351
[23]严艳,李卓,殷继明,等.北京地区乙型肝炎病毒基因型及基因亚型的分布和临床意义[J].中国误诊学杂志,2008,8(15)：3537-3539
[24]Chan H L,Wong M L,Hui A Y,et al.Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients [J].J Clin Microbiol,2003,41 (3):1277-1279
[25]Chan H L,Hui A Y,Wong M L,et al.Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma[J].Gut,2004,53(10):1494-1498
[26]许正据,杨红,陈先礼,等.重型肝炎患者乙型肝炎病毒基因型及其进化树分析[J].中华肝脏病杂志,2006,14(10)：785-787
[27]殷建华,周赟,何永超,等.乙型肝炎病毒基因亚型B2和C2对肝细胞癌形成、疗效及预后的影响[J].第二军医大学学报2008,29(2)：162-166
[28]Kao JH,Chen PJ,Lai MY,et al.Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.J Med Virol,2004,72(3):363-369
[29]KaoJH,ChenPJ,Lai MY,et al.Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection[J].J Clin Mierobiol,2002,40(4):1207-1209
[30]Wang Z,Tanaka Y,HuangY,et al.Clinical and virological characteristics of hepatitis B virus subgenotypes Ba,Cl,and C2 in China[J].J Clin Microbiol 2007,45(5):1491-1496
[31]Thakur V,Guptan RC,Kazim SN,et al.Profile,spectrum and significance of HBVgenotypes in chronic liver disease patients in thelndian subcontinent [J].J Gastroenterol Hepatol 2002,17(2):165-170
[32]Chan HL,Tsang SW,Wong ML,et al.Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong[J].Am J Gastroenterol.2002,97(10):2629-2633
[33]Chu CJ,Hussain M,Lok AS.Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C[J].Gastroenterology, 2002,122(7):1756-1762
[34]陈金军,王战会,马世武,等.HBV基因型(B/C)是影响HBeAg阳性慢性乙型肝炎患者血清HBsAg水平的重要因素[J].临床肝胆病杂志,2009,25(4)：247-250
[35]周平,谢仁江.聚乙二醇α-干扰素治疗慢性乙型肝炎的研究进展[J].世界华人消化杂志,2005,13(14)：1747-1749
[36]周霞,王宇明.乙型肝炎病毒基因分型研究进展[J].重庆医学,2008,37(1)：91-93
[37]Wai CT,Chu CJ,Hussain M,et al.HBV genotype B is associated with better response to Interferon therapy in HBeAg(+) chronic hepatitis than genotype C[J].Hepatology,2002, 36(6):1425-1430
[38]Sanchez-Tapias JM,Cost a J,Mas A,et al.Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients [J].Gastroenterology,2002, 123(6):1848-1856
[39]汤佳良,许文芳,吴勇.病毒基因型对联合抗病毒治疗慢性乙型肝炎患者HBVDNA、 HBeAg变化的影响[J].中国卫生检验杂志,2011,21(12)：2905-2906
[40]Mizokami M,Nakano T,Orito E,et al.Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns [J].FEBS Lett,1999,450(1-2):66.71.
[41]Usuda,S. H.Okamoto,T.Tanaka,et al. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product [J].J Virol Methods,2000,87(1-2):81-89.
[42]Naito,H.,S.Hayashi,and K.Abe. Rapid and specific genotyping System for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers [J].J Clin Microbiol,2001,39(1):362-364.
[43]王虹,王省良,万成松,李涛.采用微板核酸杂交-ELISA技术进行HBVDNA基因分型的研究.中华微生物和免疫学杂志,2001,21(2)：234-236.
[1]Kao J H,Chen D S.Global control of hepatitis B virus infection[J].Lancet Infect Dis,2002, 2(7):395-403
[2]Kumar K, Kumar M, Rahaman SH, et al.Distribution of Hepatitis B virus genotypes among healthy blood donors in eastern part of North India. Asian J Transfus Sci.2011,5(2): 144-149
[3]孙奎霞,李杰,闫玲,等.中国慢性乙型肝炎病毒感染者病毒基因型及基因亚型分布.中国病毒病杂志,2011,1(3)：177-182
[4]Zeng G,Wang Z,Wen S,et al.Geographic distribution,virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat.2005,12(6):609-617
[5]中华中医药学会内科肝胆病学组,世界中医药联合学会肝病专业委员会,中国中西医结合学会肝病分组.慢性乙型肝炎中医诊疗专家共识.临床肝胆病杂志,2012,28(3)：164-168.
[6]黄志杰.试论南北地域病证特点与因地制宜治则.中国中医基础医学杂志,2001,7(3)：8-10
[7]薛博瑜.慢性乙型肝炎中医临证治疗方略.药品评价,2009,6(2)：74-75
[8]叶永安,江锋,赵志敏,等.慢性乙型肝炎中医证型分布规律研究[J].中医杂志,2007,48(3)：256-258
[9]牛春红,田新强,米亚英.山西地区家族聚集性慢性乙型肝炎病毒感染者病毒载量及组织病变与基因型的关系[J].中国现代医药杂志,2009,11(7)：23-25
[10]汪莉萍,韩方正,吴光辉.HBV基因型与HBeAg的表达关系及其临床意义.临床肝胆病杂志,2011,27(5)：505-507
[11]Toan NL, Song le H, KremsnerPG, et al.Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.Hepatology,2006,43(6): 1375-1384
[12]Liu CJ, Kao JH, Chen DS.Mixed hepatitis B virus genotype infection:the more, the worse?Hepatology,2006,44(3):770-770
[13]李谋多,乔翠霞,张军勇,等.乙肝病毒携带者中医证型与HBV基因型及HBVDNA载量的关系[J].江苏中医药,2012,44(5)：18-19
[14]龙庆华,廖九女,涂德幸,等.肝活检对转氨酶轻度升高的慢性乙型肝炎的临床意义.江西医药,2009,44(5)：468-469
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |